Combating tropical infectious diseases: Report of the Disease Control Priorities in Developing Countries Project

Clinical Infectious Diseases

Volumn 38, Issue 6, 2004, Pages 871-878

  Hotez, Peter J ^a   Remme, Jan H F ^d   Buss, Paulo ^e   Alleyne, George ^b   Morel, Carlos ^d   Breman, Joel G ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; IVERMECTIN; MILTEFOSINE; NIFURTIMOX; VACCINE;

AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DENGUE; DEVELOPING COUNTRY; DIARRHEA; DISEASE CONTROL; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FILARIASIS; HEALTH CARE DELIVERY; HELMINTHIASIS; HUMAN; INFECTION; LEISHMANIASIS; LEPROSY; MALARIA; MEASLES; MEDICAL RESEARCH; NONHUMAN; ONCHOCERCIASIS; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; TRACHOMA; TROPICAL DISEASE; TUBERCULOSIS; ARTICLE; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; ECONOMICS; HEALTH; HEALTH CARE PLANNING; INFECTION CONTROL; METHODOLOGY; POLITICS; TROPICAL MEDICINE;

BIOMEDICAL RESEARCH; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DELIVERY OF HEALTH CARE; DEMOGRAPHY; DEVELOPING COUNTRIES; ECONOMICS; HEALTH PRIORITIES; HUMANS; POLITICS; TROPICAL MEDICINE; WORLD HEALTH;

EID: 1642384379     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/382077     Document Type: Review

References (43)

1. Murray C, Lopez A, eds. The global burden of disease: a comparative assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
2. World Health Organization (WHO). Annex table 3: burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2001. In: World health report, 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002:192-7.
3. Goodman RA, Foster KL, Trowbridge FK, Figueroa JP, eds. Annex A: factsheets for candidate diseases for elimination or eradication. In: Global disease elimination and eradication. Bull World Health Organ 1998; 76(Suppl):116-59.
4. Garrett L. Betrayal of trust: the collapse of global public health. New York: Hyperion, 2000.
5. Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993.
6. Remme JH, Blas E, Chitsulo L, et al. Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 2002; 18:421-6.
7. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001; 64:85-96.
8. Hotez PJ. Reducing the global burden of human parasitic diseases. Comp Parasitol 2002; 69:140-5.
9. Guerrant RL, Kosek M, Lima AA, Lorntz B, Guyatt HL. Updating the DALYs for diarrhoeal disease. Trends Parasitol 2002; 18:191-3.
10. Broder S, Hoffman SL, Hotez PJ. Cures for the third world's problems. EMBO Reports 2002; 3:806-12.
11. International Network of Field Sites with Continuous Demographic Evaluation of Populations and Their Health in Developing Countries (INDEPTH). Population health and survival at INDEPTH sites. Vol. 1. Ottawa, Canada: International Development Research Centre, 2002:1-356. Available at: http://www.indepth-network.net/publications/mortality_monograph/ indepth_mortality_monograph.htm. Accessed 25 August 2003.
12. de Savigny D, Binka F. Monitoring future progress in malaria control. Am J Trop Med Hyg (in press).
13. World Health Organization (WHO). Macroeconomics and health: investing in health for economic development report of the commission on macroeconomics and health. Geneva, Switzerland: WHO, 2001.
14. World Bank. 2003 World development indicators. Washington, DC: World Bank, 2003:3-34. Available at: http://www.un.org/millenniumgoals/. Accessed 25 August 2002.
15. Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002; 97:603-12.
16. Schmunis GA, Zicker F, Cruz, JR, Cuchi P. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am J Trop Med Hyg 2001; 65:924-30.
17. Richards FO Jr, Boatin B, Sauerbrey M, Seketeli A. Control of onchocerciasis today: status and challenges. Trends in Parasitology 2001; 17:558-63.
18. Hopkins DR, Eigege A, Miri ES, et al. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. Am J Trop Med Hyg 2002; 67:266-72.
19. Zagaria N, Savioli L. Elimination of lymphatic filariasis: a public-health challenge. Ann Trop Med Parasitol 2002; 96(Suppl 2):S3-13.
20. Bockarie MJ, Tisch, DJ, Kastens W, et al. Mass treatment to eliminate filariasis in Papua New Guinea. New Engl J Med 2002; 347:1841-8.
21. Jacobsen RR, Krahenbuhl JL. Leprosy. Lancet 1999; 353:655-60.
22. Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis 2003; 3:372-81.
23. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003; 27:1-13.
24. Halstead SB. Dengue. Curr Opin Infect Dis 2002; 15:471-6.
25. Guerin PJ, Iliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2:494-501.
26. Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new approaches to disease control. BMJ 2003; 326:377-82.
27. Stich A, Barrett MP, Krishna S. Waking up to sleeping sickness. Trends Parasitol 2003; 19:195-7.
28. Breman JG. The ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden. Am J Trop Med Hyg 2001; 64:1-11.
29. Wiseman V, Hawley WA, ter Kuile FO, et al. The cost-effectiveness of permetrhin-treated bed nets in an area of intense malaria transmission in western Kenya. Am J Trop Med Hyg 2003; 68:161-7.
30. Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 1999; 354:378-85.
31. Kosek M, Bern C, Guerrant RL. The global burden of diarrheal disease, as estimated from studies published between 1992 and 2000. Bull WHO 2003; 81:197-204.
32. Guerrant RL, Kosek M, Moor S, Lorentz B, Brantley R, Lima AAM. Magnitude and impact of diarrheal diseases. Arch Med Res 2002; 33:351-5.
33. Keusch GT. The history of nutrition: malnutrition, infection and immunity. J Nutr 2003; 133:336S-340S.
34. Savioli L, Stansfield S, Bundy DA, et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans R Soc Trop Med Hyg 2002; 96:577-9.
35. Hotez PJ, Zhan B, Bethony JM, et al. Progress in the development of a recombinant vaccine for human hookworm disease: the human hookworm vaccine initiative. Int J Parasitol 2003; 33:1245-58.
36. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
37. Dye C, Watt CJ, Bleed D. Low access to a highly effective therapy: a challenge for international tuberculosis control. Bull WHO 2002; 80:437-44.
38. Miller MA. Introducing a novel model to estimate national and global measles disease burden. Int J Infect Dis 2000; 4:14-20.
39. Global Forum for Health Research. The 10/90 report on health research, 2001-2002. Geneva, Switzerland: Global Forum for Health Research, 2002:1-224.
40. Keusch GT, Medlin C. Tapping the power of small institutions. Nature 2003; 422:561-2.
41. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361:226-34.
42. Schellenberg JA, Victora CG, Mushi A, et al. Inequities among the very poor: health care for children in rural southern Tanzania. Tanzania integrated management of childhood illness MCE baseline household survey study group. Lancet 2003; 361:561-6.
43. Hanson K, Ranson MK, Oliveira-Cruz V, Mills A. Expanding access to priority health interventions: a framework for understanding the constraints to scaling up. J Int Dev 2003; 15:1-14.